Form 4 for CDLX Cardlytics, Inc.
Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-14 · accession 0001666071-21-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-16 | 2021-07-14+ | CDLX | Laube Lynne Marie | CEO, Dir | S - Sale+OE | $123.84 | -5,514 | 310.2K | -2% | -$682.9K |
| DM | 2021-07-16 | 2021-07-14+ | CDLX | Laube Lynne Marie | CEO, Dir | M - OptEx | $20.00 | +5,514 | 310.5K | +2% | +$110.3K |
| DM | 2021-07-16 | 2021-07-14+ | CDLX | Laube Lynne Marie | CEO, Dir | M - OptEx | $0.00 | -5,514 | 44.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-14 | S | D | 300 | $125.77 | 308,332 | D | — | — | (F4) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.70 to $125.90, inclusive. |
| 2 | Common | Common Stock | 2021-07-14 | S | D | 1,100 | $124.56 | 308,632 | D | — | — | (F3) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.15 to $124.895, inclusive. |
| 3 | Common | Common Stock | 2021-07-14 | S | D | 1,976 | $123.77 | 309,732 | D | — | — | (F2) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $123.14 to $124.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4. |
| 4 | Common | Common Stock | 2021-07-14 | M | A | 3,376 | $20.00 | 311,708 | D | — | — | |
| 5 | Common | Common Stock | 2021-07-15 | M | A | 2,138 | $20.00 | 310,470 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-15 | S | D | 100 | $125.56 | 308,332 | D | — | — | |
| 7 | Common | Common Stock | 2021-07-15 | S | D | 700 | $124.95 | 308,432 | D | — | — | (F8) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.47 to $125.30, inclusive. |
| 8 | Common | Common Stock | 2021-07-15 | S | D | 638 | $123.03 | 309,132 | D | — | — | (F7) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $122.80 to $123.23, inclusive. |
| 9 | Common | Common Stock | 2021-07-15 | S | D | 400 | $122.29 | 309,770 | D | — | — | (F6) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $121.725 to $122.64, inclusive. |
| 10 | Common | Common Stock | 2021-07-15 | S | D | 300 | $120.42 | 310,170 | D | — | — | (F5) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $120.07 to $120.66, inclusive. |
| 11 | Derivative | Employee Stock Option (Right to Buy) | 2021-07-15 | M | D | 2,138 | $0.00 | 41,887 | D | $20.00 · — to 2026-08-02 | 2,138 Common Stock | (F11) Fully vested. |
| 12 | Derivative | Employee Stock Option (Right to Buy) | 2021-07-14 | M | D | 3,376 | $0.00 | 44,025 | D | $20.00 · — to 2026-08-02 | 3,376 Common Stock | (F11) Fully vested. |